Home > Boards > US OTC > Miscellaneous > Therapeutic Solutions International, Inc. (TSOI)

Thanks for the feedback. It appears QuadarMune is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
x-ray-eyes Member Profile
 
Followed By 97
Posts 6,965
Boards Moderated 0
Alias Born 03/29/12
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/3/2020 12:43:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/3/2020 12:39:56 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/29/2020 6:08:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/28/2020 12:03:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/17/2020 5:05:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/17/2020 5:01:12 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 7/10/2020 10:26:14 AM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 7/9/2020 2:56:38 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/6/2020 5:16:05 PM
Therapeutic Solutions International Universal Donor Immunotherapy StemVacs™ Activates Antiviral Immune Cells InvestorsHub NewsWire - 6/30/2020 9:00:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 6/30/2020 6:23:08 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2020 2:42:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2020 2:36:40 PM
Therapeutic Solutions International Announces Intention to Use Clinical Stage NK Activating Cancer Immunotherapy InvestorsHub NewsWire - 6/22/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 1:17:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 1:14:11 PM
Therapeutic Solutions International Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway InvestorsHub NewsWire - 6/15/2020 7:06:21 AM
Therapeutic Solutions International Issues "NOT US" Notice to Shareholders InvestorsHub NewsWire - 6/14/2020 8:10:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 3:26:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 3:23:57 PM
Therapeutic Solutions International Reports QuadraMune Reduces Myeloid Suppressor Cells in 4T1 Mouse Model of Breast Cancer New InvestorsHub NewsWire - 6/11/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2020 1:46:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/9/2020 1:29:30 PM
Therapeutic Solutions International Initiates 500 Volunteer COVID-19 Prevention Clinical Trial Using QuadraMune™ InvestorsHub NewsWire - 6/8/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2020 12:14:34 PM
x-ray-eyes   Tuesday, 06/30/20 08:55:26 AM
Re: Yooperman post# 24399
Post # of 27310 
Thanks for the feedback. It appears QuadarMune is reducing inflammation quickly for you. Glad to hear you are getting results in days, which is an indication for me as to how truly effective the formula is to see results that quick.

glty





Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist